Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: Comparison with OctreoScan® in two cases

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Cossetti, Rachel Jorge D ^a   Bezerra, Regis Otaviano F ^a   Gumz, Brenda ^a   Telles, Adriana ^a   Costa, Frederico P ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Diffusion weighted image; Magnetic resonance image; Neuroendocrine tumor; OctreoScan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A; CYTOKERATIN; EVEROLIMUS; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SYNAPTOPHYSIN;

ADENOCARCINOMA; ADULT; ARTICLE; BONE METASTASIS; BRONCHOSCOPY; BRONCHUS; BRONCHUS INJURY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FEMALE; HEMOPTYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER INJURY; LIVER METASTASIS; LIVER NODULE; LIVER RESECTION; LUNG LOBECTOMY; LUNG NODULE; LUNG RESECTION; MALE; MEDIASTINUM LYMPH NODE; MITOSIS; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY NEUROENDOCRINE TUMOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS NODULE; URINALYSIS; WHOLE BODY IMAGING; WHOLE BODY SCINTISCANNING;

ADULT; BONE NEOPLASMS; BRONCHIAL NEOPLASMS; CARCINOMA, NEUROENDOCRINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; SOMATOSTATIN; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84867592693     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-82     Document Type: Article

References (16)

1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey J-N, Rashid A, Evans DB. One hundred years after " carcinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008, 26:3063-3072. 10.1200/JCO.2007.15.4377, 18565894.
2. Norton JA. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. Best Pract Res Clin Gastroenterol 2005, 19:577-583. 10.1016/j.bpg.2005.04.003, 16183528.
3. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzilli R, Corinaldesi R. Endocrine pancreatic tumors:factors correlated with survival. Ann Oncol 2005, 16:1806-1810. 10.1093/annonc/mdi358, 16085691.
4. Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 2000, 190:432-445. 10.1016/S1072-7515(00)00222-2, 10757381.
5. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990, 108:1091-1096.
6. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999, 24:456-461. 10.1007/s002619900539, 10475927.
7. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008, 18:486-492. 10.1007/s00330-007-0798-4, 17994317.
8. Liapi E, Geschwind JF, Vossen JA, Buijs M, Georgiades CS, Bluemke DA, Kamel IR. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol 2008, 190:67-73. 10.2214/AJR.07.2550, 18094295.
9. Anaye A, Mathieu A, Closset J, Bali MA, Metens T, Matos C. Successful preoperative localization of a small pancreatic insulinoma by diffusion-weighted MRI. JOP 2009, 10:528-531.
10. Dromain C, de Baere T, Baudin E, Galline J, Ducreux M, Boige V, Duvillard P, Laplanche A, Caillet H, Lasser P, Schlumberger M, Sigal R. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR Am J Roentgenol 2003, 180:121-128.
11. Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Feugeas MC, Cadiot G, Mignon M, Schouman-Claeys E. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 2001, 74:1065-1070.
12. Ambrosini V, Campana D, Bodei L, Nanni C, Castellucci P, Allegri V, Montini GC, Tomassetti P, Paganelli G, Fanti S. 68 Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors. J Nucl Med 2010, 51:669-673. 10.2967/jnumed.109.071712, 20395323.
13. Campana D, Ambrosini V, Pezzilli R, Fanti S, Labate AM, Santini D, Ceccarelli C, Nori F, Franchi R, Corinaldesi R, Tomassetti P. Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nucl Med 2010, 51:353-359. 10.2967/jnumed.109.066662, 20150249.
14. Tan EH, Tan CH. Imaging of gastroenteropancreaticneuroendocrine tumors. World J Clin Oncol 2011, 2:28-43. 10.5306/wjco.v2.i1.28, 3095463, 21603312.
15. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Régent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol 2010, 75:376-383. 10.1016/j.ejrad.2009.04.059, 19497694.
16. Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18FFDG positron emission tomography and 123I-MIBG scintigraph. Ann Nucl Med 2008, 22:395-401. 10.1007/s12149-008-0128-1, 18600417.